Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Moultrie

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Plos One|March 9, 2011
Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatmentCordula Frohoff, Magendhree Moodley, Lee Fairlie, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four wavesJeremy Bingham, Stefano Tempia, Harry Moultrie, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South AfricaTammy Meyers, Shobna Sawry, Jessica Y Wong, et al.
Plos One|September 22, 2023
Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four wavesJeremy Bingham, Stefano Tempia, Harry Moultrie, et al.
AIDS (London, England)|June 19, 2010
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatmentMarcel Yotebieng, Annelies Van Rie, Harry Moultrie, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2014
Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavirHarry Moultrie, Helen McIlleron, Shobna Sawry, et al.
BMC Health Services Research|August 15, 2020
A geospatial analysis of two-hour surgical access to district hospitals in South AfricaKathryn M Chu, Angela J Dell, Harry Moultrie, et al.
PLOS Global Public Health|March 24, 2023
Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level dataMariet Benade, Lawrence Long, Gesine Meyer-Rath, et al.
AIDS (London, England)|September 28, 2012
Cost and outcomes of paediatric antiretroviral treatment in South AfricaGesine Meyer-Rath, Alana Brennan, Lawrence Long, et al.
PLOS Global Public Health|July 3, 2023
The role of modelling and analytics in South African COVID-19 planning and budgetingGesine Meyer-Rath, Rachel A Hounsell, Juliet Rc Pulliam, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Plos One|March 9, 2011
Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatmentCordula Frohoff, Magendhree Moodley, Lee Fairlie, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four wavesJeremy Bingham, Stefano Tempia, Harry Moultrie, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South AfricaTammy Meyers, Shobna Sawry, Jessica Y Wong, et al.
Plos One|September 22, 2023
Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four wavesJeremy Bingham, Stefano Tempia, Harry Moultrie, et al.
AIDS (London, England)|June 19, 2010
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatmentMarcel Yotebieng, Annelies Van Rie, Harry Moultrie, et al.
The Journal of Antimicrobial Chemotherapy|October 5, 2014
Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavirHarry Moultrie, Helen McIlleron, Shobna Sawry, et al.
BMC Health Services Research|August 15, 2020
A geospatial analysis of two-hour surgical access to district hospitals in South AfricaKathryn M Chu, Angela J Dell, Harry Moultrie, et al.
PLOS Global Public Health|March 24, 2023
Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level dataMariet Benade, Lawrence Long, Gesine Meyer-Rath, et al.
AIDS (London, England)|September 28, 2012
Cost and outcomes of paediatric antiretroviral treatment in South AfricaGesine Meyer-Rath, Alana Brennan, Lawrence Long, et al.
PLOS Global Public Health|July 3, 2023
The role of modelling and analytics in South African COVID-19 planning and budgetingGesine Meyer-Rath, Rachel A Hounsell, Juliet Rc Pulliam, et al.
Pageof 7